Korean J Med.
2016 Mar;90(3):198-205. 10.3904/kjm.2016.90.3.198.
The Role of Antiarrhythmics in Atrial Fibrillation
- Affiliations
-
- 1Institute of Cardiovascular Research, Divison of Cardiology, Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea. ksee@jbnu.ac.kr
- KMID: 2155932
- DOI: http://doi.org/10.3904/kjm.2016.90.3.198
Abstract
- Atrial fibrillation (Afib) is the most common arrhythmia with clinical significance, and its incidence increases with advanced age. Afib is associated with a 3- to 5-fold increased risk of stroke, a 3-fold increase in the risk of heart failure, and higher mortality than without Afib. The treatment of Afib is multifold but revolves around one essential issue: whether to attempt to restore sinus rhythm or to simply control the ventricular rate. This decision depends on symptom severity, the age of the patient, underlying heart disease, and other comorbidities that may limit therapeutic options. The management of Afib with antiarrhythmic medications was reviewed.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation
- How and When to Screen for Atrial Fibrillation after Stroke: Insights from Insertable Cardiac Monitoring Devices
- Pathophysiology and Diagnosis in Atrial Fibrillation
- Pharmacological Treatment of Atrial Fibrillation
- Would Left Atrial Strain Provide a Role as a New Prognostigator for Atrial Fibrillation?
